Lybrate Funding: How Much Did They Raise & Key Investors

How Much Did Lybrate Raise?
Funding & Key Investors

Lybrate has solidified its position within the digital health ecosystem, securing a total capital infusion of $14.4M. This trajectory of financial support, punctuated by a recent strategic investment of $3M, underscores the platform's critical role in bridging the gap between patients and medical professionals. By leveraging these resources, the company continues to scale its operations across India, reinforcing its commitment to accessible, high-quality healthcare delivery.

The firm's growth story is marked by a series of deliberate financing rounds, beginning with initial backing in 2014, followed by a significant Series A expansion in 2015, and culminating in the most recent capital injection in 2017. This progression highlights investor confidence in Lybrate's ability to disrupt traditional healthcare models through technology-driven solutions.

What is Lybrate?

Lybrate

Software

Healthcare Software

Mobile App Development

Lybrate operates as a premier patient consulting portal, effectively digitizing the healthcare experience for millions of users. By connecting patients with a network of over 150,000 doctors across diverse medical specialties—ranging from proctology and gynecology to urology and aesthetics—the platform facilitates seamless online consultations and appointment scheduling. Its market position is defined by its extensive reach, spanning major metropolitan hubs as well as Tier-2 and Tier-3 towns, thereby democratizing access to expert medical advice. The company's infrastructure is designed to provide a holistic healthcare journey, ensuring that patients receive timely and comprehensive care regardless of their geographic location.

How much funding has Lybrate raised?

Lybrate has raised a total of $14.4M across 3 funding rounds:

2014

Private Equity

$1.2M

2015

Series A

$10.2M

2017

Private Equity

$3M

Private Equity (2014): $1.2M with participation from Nexus Venture Partners

Series A (2015): $10.2M led by Nexus Venture Partners

Private Equity (2017): $3M, investors not publicly disclosed

Key Investors in Lybrate

Nexus Venture Partners

Nexus Venture Partners is a prominent venture capital firm specializing in seed, startup, growth capital, and early-stage investments with a global investment perspective.

Undisclosed Investor

Undisclosed investor participating in the funding round.

What's next for Lybrate?

With the successful acquisition of $3M, Lybrate is well-positioned to accelerate its strategic roadmap. Future initiatives are expected to focus on deepening the platform's technological capabilities, potentially integrating advanced diagnostic tools and expanding its footprint in underserved regions. As the digital health sector continues to mature, Lybrate's focus on operational efficiency and user-centric service delivery will be paramount in maintaining its competitive edge. The company is likely to prioritize the enhancement of its telemedicine infrastructure, ensuring that it remains the primary interface for patient-doctor interactions in an increasingly digital-first healthcare landscape.

See full Lybrate company page

See More Financial Insights